Publications by authors named "Malin Ryner"

Claim this Profile
L
Longitudinal analysis of anti-drug antibody development in multiple sclerosis patients treated with interferon beta-1a (Rebif™) using B cell receptor repertoire analysis.
Linda van der Weele, Sabrina Pollastro, Barbera D C van Schaik, Antoine H C van Kampen, Ilse T G Niewold, Malin Ryner

J Neuroimmunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short report: Real-life analysis of the occurrence of persistent, transient, and fluctuating positive titres of neutralizing anti-drug antibodies in multiple sclerosis patients treated with interferon beta.
Matilde Oviedo Querejazu, Nicky Dunn, Ryan Ramanujam, Malin Ryner, Michael Auer

Mult Scler Relat Disord· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis.
Francesca Faustini, Nicky Dunn, Nastya Kharlamova, Malin Ryner, Annette Bruchfeld

Arthritis Res Ther· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier.
Nastya Kharlamova, Christina Hermanrud, Nicky Dunn, Malin Ryner, Karen Hambardzumyan

Front Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS.
Till F M Andlauer, Jenny Link, Dorothea Martin, Malin Ryner, Christina Hermanrud

BMC Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium.
Signe Hässler, Delphine Bachelet, Julianne Duhaze, Natacha Szely, Aude Gleizes, Malin Ryner

PLoS Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of natalizumab anti-drug antibodies persistency.
Florian Deisenhammer, Marlies Jank, Anna Lauren, Anders Sjödin, Malin Ryner

Mult Scler· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection and kinetics of persistent neutralizing anti-interferon-beta antibodies in patients with multiple sclerosis. Results from the ABIRISK prospective cohort study.
Poul Erik H Jensen, Clemens Warnke, Kathleen Ingenhoven, Luca Piccoli, Marcia Gasis, Malin Ryner

J Neuroimmunol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies.
Nicky Dunn, Alexander Juto, Malin Ryner, Ali Manouchehrinia, Luca Piccoli

Mult Scler· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical practice of analysis of anti-drug antibodies against interferon beta and natalizumab in multiple sclerosis patients in Europe: A descriptive study of test results.
Jenny Link, Ryan Ramanujam, Michael Auer, Malin Ryner, Signe Hässler

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of an Enzyme-Linked Immunosorbent Assay for the Detection of Binding Anti-Drug Antibodies against Interferon Beta.
Kathleen Ingenhoven, Daniel Kramer, Poul Erik Jensen, Christina Hermanrud, Malin Ryner

Front Neurol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis.
Delphine Bachelet, Signe Hässler, Cyprien Mbogning, Jenny Link, Malin Ryner

PLoS One· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of cell-based luciferase reporter gene assays for measuring neutralizing anti-drug antibodies against interferon beta.
Christina Hermanrud, Malin Ryner, Thomas Luft, Poul Erik Jensen, Kathleen Ingenhoven

J Immunol Methods· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-interferon beta antibody titers strongly correlate between two bioassays and in vivo biomarker expression, and indicates that a titer of 150 TRU/mL is a biologically functional cut-point.
Christina Hermanrud, Malin Lundkvist Ryner, Elin Engdahl, Anna Fogdell-Hahn

J Interferon Cytokine Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a.
Anna Karin Hedström, Malin Ryner, Katarina Fink, Anna Fogdell-Hahn, Lars Alfredsson

Mult Scler· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis